New enantioenriched β ‐indolyl ketones as aromatase inhibitors: Unraveling heme–ligand interactions by MD simulation and MMPBSA analysis
Archiv der Pharmazie · 2024-07 · 357 (7)
DOI: 10.1002/ardp.202400010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archiv der Pharmazie, online erschienen am 05.04.2024. Verfasst von Maira Hasnain Pasha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Faculty of Science, University of Sargodha, Sargodha, Pakistan. Hauptthemen laut MEDLINE: Indoles, Molecular Docking Simulation, Ketones, Aromatase Inhibitors. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 79 Literaturangaben. Gefördert von: Deanship of scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU).
Abstract (Originalsprache)
A series of enantioenriched β ‐indolyl ketones as aromatase inhibitors (AI) is synthesized through the Michael‐type Friedel–Crafts alkylation of indole. A highly efficient bifunctionalized amino catalyst is developed to access structurally diverse β ‐indolyl ketones in high yields (up to 91%) and excellent enantioselectivity (enantiomeric ratio up to 98:2). All the synthesized compounds demonstrated promising aromatase inhibitory potential, where ortho ‐substituted analogs ( 3c and 3e ) were found most active with IC 50 values of 0.68 and 0.90 µM, respectively. Both of these compounds exhibited significant cytotoxicity (IC 50 = 0.34 and 0.37 µM) against the MCF‐7 breast cancer cell line in the (3‐[4,5‐dimethylthiazol‐2‐yl]‐2,5‐diphenyl tetrazolium bromide) assay. Molecular docking studies of the synthesized compounds demonstrate favorable binding interactions with the estrogens controlling CYP19A1 (3EQM) and metabolizing CYP3A4 (5VCC) enzymes. Molecular dynamic (MD) simulation analysis revealed the essentiality of heme–ligand interactions to build a stable protein–ligand complex. An average root mean square deviation of 0.35 nm observed during a 100‐ns MD simulation and binding free energy in the range of −190 to −227 kJ/mol calculated by g_mmpbsa analysis authenticated the stability of the 3c –3EQM complex. ADMET and drug‐likeness parameters supported the suitability of these indole derivatives as the drug lead to develop potent inhibitors for estrogen‐dependent breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemistry, Faculty of Science, University of Sargodha, Sargodha, Pakistan.
- Department of Chemistry, College of Science, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Förderung
- Deanship of scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU)
Zitieren
APA
Pasha, M. H., Gondal, H. Y., Munir, S., Alhussain, S. A., & Zaki, M. E. A. (2024). New enantioenriched β ‐indolyl ketones as aromatase inhibitors: Unraveling heme–ligand interactions by MD simulation and MMPBSA analysis. Archiv der Pharmazie, 357(7). https://doi.org/10.1002/ardp.202400010
Vancouver
Pasha MH, Gondal HY, Munir S, Alhussain SA, Zaki MEA. New enantioenriched β ‐indolyl ketones as aromatase inhibitors: Unraveling heme–ligand interactions by MD simulation and MMPBSA analysis. Archiv der Pharmazie. 2024;357(7). doi:10.1002/ardp.202400010
BibTeX
@article{Pasha2024,
author = {Pasha, Maira Hasnain and Gondal, Humaira Yasmeen and Munir, Shanza and Alhussain, Sami A and Zaki, Magdi E A},
title = {New enantioenriched β ‐indolyl ketones as aromatase inhibitors: Unraveling heme–ligand interactions by MD simulation and MMPBSA analysis},
journal = {Archiv der Pharmazie},
year = {2024},
volume = {357},
number = {7},
doi = {10.1002/ardp.202400010}
}
EUVIMED